PTEN functions as a tumor inhibitor by decreasing the activity of phosphoinositide 3-kinase (PI3K) (Bian et al., 2018), and its expression diminished with the progression of UCEC (Xi et al., 2019). This evidence concerns the gene PIK3CA and neoplasm.